← Leaderboards
Randa A El-Zein
University Of Texas Md Anderson Can Ctr
$5,185,619
Attributed
$7,597,755
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,597,755 · 7
By mechanism
R01$3,990,878 · 3
U01$2,859,434 · 1
R21$381,150 · 1
P01$216,293 · 1
R03$150,000 · 1
Top collaborators
- Isabelle Bedrosian5 shared
- Nagireddy Putluri5 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Margaret R Spitz$17,223,484
- Qingyi Wei$12,754,141
- Scott M Lippman$54,535,308
- Jeffrey E Gershenwald$4,596,979
- Claudio J Conti$3,439,402
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBaseTissuesCohortRisk AssessmentBiological MarkersDetectionDna RepairTumorDna DamageMolecularTreatment StrategyEpidemiologyEarly DiagnosisNitrosaminesCase ControlMalignant Neoplasm Of LungCancer PatientCancer EtiologyImageLesionLungAdductHigh Risk
Grant awards (21)
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers$375,540
R01 · FY2022 · CA
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers$387,196
R01 · FY2021 · CA
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers$391,127
R01 · FY2020 · CA
Integrative molecular and imaging approaches for risk of subtype specific breast$552,694
U01 · FY2019 · CA · contact PI
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers$383,157
R01 · FY2019 · CA
Integrative molecular and imaging approaches for risk of subtype specific breast$572,435
U01 · FY2018 · CA · contact PI
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers$427,819
R01 · FY2018 · CA
Integrative molecular and imaging approaches for risk of subtype specific breast$572,435
U01 · FY2017 · CA · contact PI
Integrative molecular and imaging approaches for risk of subtype specific breast$566,060
U01 · FY2016 · CA · contact PI
Integrative molecular and imaging approaches for risk of subtype specific breast$595,810
U01 · FY2015 · CA · contact PI
Cross regulation of TGSB/elf, B-catenin and vitamin D pathways in Gastrointestin$216,293
P01 · FY2013 · CA · contact PI
Validation and extension of an existing risk model for lung cancer$615,470
R01 · FY2010 · CA · contact PI
Cytokinesis-blocked micronucleus assay: a predictive biomarker of lung cancer ris$138,600
R21 · FY2009 · CA · contact PI
Cytokinesis-blocked micronucleus assay: a predictive biomarker of lung cancer ris$242,550
R21 · FY2008 · CA · contact PI
Molecular Biomarkers as Predictors of Hodgkin's Disease$286,708
R01 · FY2007 · CA · contact PI
Molecular Biomarkers as Predictors of Hodgkin's Disease$295,271
R01 · FY2006 · CA · contact PI
Molecular Biomarkers as Predictors of Hodgkin's Disease$268,780
R01 · FY2005 · CA
Molecular Biomarkers as Predictors of Hodgkin's Disease$268,780
R01 · FY2004 · CA
Molecular Biomarkers as Predictors of Hodgkin's Disease$291,030
R01 · FY2003 · CA
MOLECULAR BIOMARKERS FOR PROSTATE CANCER SUSCEPTIBILITY$75,000
R03 · FY2001 · CA
MOLECULAR BIOMARKERS FOR PROSTATE CANCER SUSCEPTIBILITY$75,000
R03 · FY2000 · CA